Binnopharm Group increased the capacity of the antipyretic production site at the Synthesis plant
| Customers: Synthesis Kurgan Society of Medicines and Products
Contractors: Romaco Project date: 2021/07 - 2022/01
|
2021: Refurbishment of syrup and suspension production site
The pharmaceutical company Binnopharm Group on February 11, 2022 announced the completion of the renovation of the site for the production of preparations in the form of syrups and suspensions at the Synthesis plant in Kurgan. This will increase the production of drugs in this form by three times - up to 6 million bottles per year.
 | We completed the renewal of the syrup and suspension production site: we installed other equipment, and also reconstructed the premises in accordance with the latest requirements, "commented Boris Zhorov, executive director of the Binnofarm Group production site in Kurgan. - This is very important, because the pandemics nomenclature, which is extremely popular during the period - antipyretic drugs, along with non-steroidal anti-inflammatory and mucolytic drugs, is produced in this area. Increasing production capacity will allow us to increase the output of this category of drugs if necessary. |  |
The supplier of equipment was the Italian company Romaco (part of one of the world manufacturers of pharmaceutical equipment - ECI holding).
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |